THREAD: SGLT2 inhibitors for #diabetes
1/5 Dr. Jamie Falk @jamisonfalk presented "A Deep Dive into #SGLT2i: What Comes to the Surface for Individuals with Diabetes"
👉🏽Watch the presentation here: bit.ly/3FRCEoM 🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd
2/5 #AdverseEffects for #SGLT2i to be aware of: genital infections, hypovolemia, DKA, amputations
✅Check out the image ⬇️ for the risk estimates
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes #ptsafety
3/5 Evidence to date for #SGLT2i:
The first of the two new classes of medications for type II diabetes to reduce ↘️ risk of CV #AdverseEvents and mortality
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes
4/5 Pros and cons of #SGLT2inhibitors ⚖️
#SGLT2i also lead to #WeightLoss; the opposite of what insulin and sulfonylureas do
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#T2DM #medsafety #FOAMed #MedEd #diabetes
5/5 Dr. Falk also compares effects of #SGLT2i💊to the evidence for #PhysicalActivity in people with #T2DM🚶🏾♂️🚴🏾♂️🏊🏾♂️
✅Watch @JamisonFalk's presentation here: bit.ly/3FRCEoM🧑🏾💻
#medsafety #FOAMed #MedEd #diabetes #exercise
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.